Athena Athena

X

Find Radio Compass News for Dutasteride

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • CAPSULE;ORAL - 0.5MG
  • CAPSULE;ORAL - 0.5MG;0.4MG

https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416

FDA
01 Feb 2023

https://www.fiercepharma.com/manufacturing/china-suspends-import-gsks-avodart-after-plant-inspection

Kevin Dunleavy FIERCEPHARMA
01 Nov 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf

FDA
17 Nov 2021

https://www.prnewswire.com/news-releases/published-study-pycnogenol-measurably-improved-symptoms-related-to-enlarged-prostate-within-60-days-300751373.html

PR NEWSWIRE
16 Nov 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208227

FDA
27 Jun 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207769

FDA
29 May 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207769

FDA
26 May 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209909

FDA
27 Nov 2017

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2017-1510120910.pdf

FDA
08 Nov 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207935

FDA
17 Oct 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090701

FDA
07 Oct 2017

https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-marksans-pharma-ltd-1502348339.pdf

FDA
25 Apr 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204376

FDA
12 Apr 2017

https://www.pharmacompass.com/pdf/news/ascents-generic-dutasteride-received-approval-in-us-1477569216.pdf

FDA
22 Oct 2016

http://raps.org/Regulatory-Focus/News/2016/09/16/25864/EMA-Recommends-Ban-of-US-CMO%E2%80%99s-Medicines/

Zachary Brennan RAPS
16 Sep 2016

http://www.in-pharmatechnologist.com/Drug-Delivery/ANSM-lifts-manufacturing-ban-at-Catalent-softgel-plant

Dan Stanton IN-PHARMATECHNOLOGIST
02 May 2016

https://www.pharmacompass.com/pdf/news/intergels-generic-dutasteride-approved-in-us-1458382122.pdf

FDA
17 Mar 2016

http://www.koreaherald.com/view.php?ud=20160122000522

THE KOREAN HERALD
21 Jan 2016

http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt

Gareth MacDonald IN-PHARMA TECHNOLOGIST
03 Dec 2015

http://www.prnewswire.com/news-releases/impax-launches-generic-version-of-avodart-dutasteride-capsules-05-mg-300183861.html

PR NEWS WIRE
24 Nov 2015

https://www.pharmacompass.com/pdf/news/apotexs-generic-dutasteride-approved-in-us-for-symptomatic-bph-in-men-1448540670.pdf

FDA
24 Nov 2015

https://www.pharmacompass.com/pdf/news/roxanes-generic-dutasteride-approved-in-us-for-symptomatic-bph-in-men-1448540573.pdf

FDA
24 Nov 2015

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-shasun-gets-usfda-nod-to-market-dutasteride-capsules/articleshow/49872254.cms

ECONOMIC TIMES
23 Nov 2015

https://www.pharmacompass.com/pdf/news/banners-generic-dutasteride-approved-in-us-for-symptomatic-bph-in-men-1448444638.pdf

FDA
20 Nov 2015

https://www.pharmacompass.com/pdf/news/vintages-generic-dutasteride-approved-in-us-for-symptomatic-bph-in-men-1448444670.pdf

FDA
20 Nov 2015

https://www.pharmacompass.com/pdf/news/risings-generic-dutasteride-approved-in-us-for-symptomatic-bph-in-men-1448444580.pdf

FDA
20 Nov 2015

https://www.pharmacompass.com/pdf/news/actavis-generic-dutasteride-tamsulosin-hcl-approved-in-us-for-bph-in-men-1448541422.pdf

FDA
20 Nov 2015

https://www.pharmacompass.com/pdf/news/sandozs-generic-dutasteride-approved-in-us-for-symptomatic-bph-in-men-1448540934.pdf

FDA
20 Nov 2015

https://www.pharmacompass.com/pdf/news/breckenridges-generic-dutasteride-approved-in-us-for-gastric-ulcer-1448540541.pdf

FDA
20 Nov 2015

https://www.pharmacompass.com/pdf/news/strides-generic-dutasteride-approved-in-us-for-gastric-ulcer-1448540508.pdf

FDA
20 Nov 2015

http://www.prnewswire.com/news-releases/breckenridge-announces-final-approval-for-dutasteride-soft-gelatin-capsules-300182574.html

PR NEWS WIRE
20 Nov 2015

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/05/another-punt-return-resolving-180-day-exclusivity-this-time-a-true-post-mma-case-made-in-the-context.html

Kurt R. Karst FDA LAW BLOG
18 May 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY